In a study in streptozotocin-induced diabetic mice, MCC950 was also found to delay the development of various complications associated with diabetes, including diabetic retinopathy, diabetes-associated atherosclerosis, and diabetic encephalopathy, by inhibiting the NLRP3 inflammasome and its downstream inflammatory response (144–146). Here, NLRP3 is linked to diabetes mellitus.